Work

Randomized phase II trial of NGR-hTNF with an anthracycline in platinum-refractory or -resistant ovarian cancer (OC).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.5523

Authors: Domenica Lorusso, Giovanni Scambia, Nicoletta Colombo, Nicholas Reed, Carmen Pisano, Rosemary Lord, Giorgia Mangili, Annamaria Mosconi, Francesco Raspagliesi, Antonella Palazzo, Antonino Ditto, Vanda Salutari, Carmine Conte, Giulia Amadio, Antonio Lambiase, Claudio Bordignon

Institutions: European Institute of Oncology, Beatson West of Scotland Cancer Centre, Clatterbridge Cancer Centre NHS Foundation Trust, IRCCS Ospedale San Raffaele, MolMed (Italy)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2906836021

Cites:

Cited by: 2

Related to: 10